TAP1 gene polymorphisms and nasopharyngeal carcinoma risk in a Tunisian population

Cancer Genetics and Cytogenetics

Volumn 175, Issue 1, 2007, Pages 41-46

  Hassen, Elham ^a   Farhat, Karim ^a   Gabbouj, Sallouha ^a   Jalbout, Majida ^b   Bouaouina, Noureddine ^a,c   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLYCINE; ISOLEUCINE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; VALINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; ONSET AGE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TUNISIA;

ADOLESCENT; ADULT; AGED; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; TUNISIA;

EID: 34247897130     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.01.009     Document Type: Article

References (19)

1. Parkin D.M., and Muir C.S. Cancer incidence in five continents: comparability and quality of data. IARC Sci Publ 120 (1992) 45-173
2. Cammoun M., Hoerner V., and Mourali N. Tumors of the nasopharynx in Tunisia: an anatomic and clinical study based on 143 cases. Cancer 331 (1974) 184-192
3. Jeannel D., Hubert A., de Vathaire F., Ellouz R., Camoun M., Ben Salem M., Sancho-Garnier H., and de-The G. Diet, living conditions and nasopharyngeal carcinoma in Tunisia: a case-control study. Int J Cancer 46 (1990) 421-425
4. Old L.J., Boyse E.A., Oettgen H.F., De Haven E., Geering G., Williamson B., and Clifford P. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 56 (1966) 1699-1704
5. Chan S.H., Day N.E., Kunaratnam N., Chia K.B., and Simons M.J. HLA and nasopharyngeal carcinoma in Chinese: a further study. Int J Cancer 32 (1983) 171-176
6. Mokni-Baizig N., Ayed K., Ayed F.B., Ayed S., Sassi F., Ladgham A., Bel Hadj O., and El May A. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia. Oncology 61 (2001) 55-58
7. Powis S.H., Tonks S., Mockridge I., Kelly A.P., Bodmer J.G., and Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 37 (1993) 373-380
8. Sobin L.H., and Fleming I.D. TNM classification of malignant tumours, 5th ed. Union Internationale Centre le Cancer and the American Joint Committee on Cancer. Cancer 80 (1997) 1803-1804
9. Ben Abdallah M. Epidémiologie des cancers en Tunisie: registre de l'Institut Salah Azaiz (1994-1999) (2004), Association tunisienne de lutte contre le cancer, Tunis
10. Lee S.P., Chan A.T., Cheung S.T., Thomas W.A., CroomCarter D., Dawson C.W., Tsai C.H., Leung S.F., Johnson P.J., and Huang D.P. CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol 165 (2000) 573-582
11. Gostout B.S., Poland G.A., Calhoun E.S., Sohni Y.R., Giuntoli II R.L., McGovern R.M., Sloan J.A., Cha S.S., and Persing D.H. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 88 (2003) 326-332
12. Quadri S.A., and Singal D.P. Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism. Immunol Lett 61 (1998) 25-31
13. Nijenhuis M., and Hammerling G.J. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J Immunol 157 (1996) 5467-5477
14. Alvarado-Guerri R., Cabrera C.M., Garrido F., and Lopez-Nevot M.A. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an eastern Andalusian population. Hum Immunol 66 (2005) 921-930
15. Jalbout M., Bouaouina N., Gargouri J., Corbex M., Ben Ahmed S., and Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 193 (2003) 75-81
16. Dardari R., Khyatti M., Jouhadi H., Benider A., Ettayebi H., Kahlain A., Mansouri A., El Gueddari B., and Benslimane A. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 92 (2001) 294-297
17. Chan S.H., Chew C.T., Prasad U., Wee G.B., Srinivasan N., and Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer 51 (1985) 3389-3392
18. Khabir A., Sellami A., Sakka M., Ghorbel A.M., Daoud J., Frikha M., Drira M.M., Busson P., and Jlidi R. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 6 (2000) 3932-3936 [Erratum in: Clin Cancer Res 2001;7:220]
19. Khabir A., Ghorbel A., Daoud J., Frikha M., Drira M.M., Laplanche A., Busson P., and Jlidi R. Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detect Prev 27 (2003) 250-255